Development of Rosuvastatin calcium oral tablet bioequivalent with Crestatinâ -Investigate the degradation of this product by a Stability- Indicating LC Method
碩士 === 大仁科技大學 === 製藥科技研究所 === 100 === Rosuvastatin calcium, bis [(E)-7 [4-(4-fluorophenyl)-6 isopropyl- 2-[methyl (methyl-sulphonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxyhept-6-enoic acid] calcium salt, was approved by the US FDA in August 2003 to reduce cholesterol levels in patients with...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/38793410768564788803 |